Focus on Asthma Care

Back to articles

Triple therapy in a single inhaler improves asthma symptoms and control, studies show

KEY POINT

Addition of a long-acting muscarinic antagonist (LAMA) to inhaled corticosteroid (ICS) plus long-acting beta-2-agonist (LABA) therapy improved lung function and reduced exacerbations in adults with uncontrolled asthma, according to an analysis of two clinical trials published in the Lancet.